Skip to main content
x

Interim VIS for Human Papillomavirus vaccine

Rating
On September 5, CDC released an interim VIS for human papillomavirus (HPV) vaccine. The final VIS will be developed after ACIP recommendations are published in MMWR and the vaccine is covered by the Vaccine Injury Compensation Program.